Company Manitex Capital Inc.

MNX

CA56342H2000

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sector Other Pharmaceuticals

Market Closed - Toronto S.E. Other stock markets 20:08:48 07/05/2024 BST			5-day change	1st Jan Change
0.16 ^CAD	+6.67%		0.00%	-30.43%

03-29	Manitex Capital Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	CI
02-28	Manitex Capital Inc. Reports Earnings Results for the Full Year Ended October 31, 2023	CI

Manitex Capital Inc. is a Canada-based Diversified investment company. The Company is specialized in investing in emerging as well as established companies in diversified sectors, including life sciences and sustainable products/technologies. The Company also holds an extensive portfolio in marketable securities in companies in the same fields.

Managers	Title	Age	Since
Steven Saviuk CEO	Chief Executive Officer	65	01/10/86
Helen Saviuk DFI	Director of Finance/CFO	71	28/03/10
Guy-Paul Allard LAW	General Counsel	56	31/12/16

Members of the board	Title	Age	Since
Michael Tinmouth BRD	Director/Board Member	-	27/04/04
Steven Saviuk CEO	Chief Executive Officer	65	01/10/86
Helen Saviuk DFI	Director of Finance/CFO	71	28/03/10
Marc Bélair BRD	Director/Board Member	-	02/04/20

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	12,661,276	4,880,389 ( 38.55 %)	0	38.55 %

Name	Equities	%	Valuation
Simcor Canada Holdings, Inc. 47.52 %	6,016,542	47.52 %	896 465 $
Steven Saviuk 9.023 %	1,142,400	9.023 %	170 218 $
Helen Saviuk 3.438 %	435,345	3.438 %	64 866 $
Natasha Saviuk 0.6950 %	88,000	0.6950 %	13 112 $
Michael Tinmouth 0.000000 %	0	0.000000 %	- $

Name	Equities	%	Valuation
VALEO PHARMA INC. 25.72%	25,372,987	25.72%	1,649,244 $
CHITOGENX INC. 10.34%	5,275,392	10.34%	242,668 $

Manitex Capital, Inc.

16667 Hymus Boulevard

H9H 4R9, Kirkland

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
MANITEX CAPITAL INC.	-30.43%	1.49M
ELI LILLY AND COMPANY	+32.09%	694B
NOVO NORDISK A/S	+29.39%	593B
JOHNSON & JOHNSON	-1.34%	371B
MERCK & CO., INC.	+20.34%	331B
ABBVIE INC.	+7.39%	290B
ASTRAZENECA PLC	+14.25%	239B
ROCHE HOLDING AG	-3.03%	209B
NOVARTIS AG	+10.02%	209B
AMGEN INC.	+8.49%	169B

Other Pharmaceuticals